[Retracted] Efficacy and Prediction Model Construction of Drug-Coated Balloon Combined with Cutting Balloon Angioplasty in the Treatment of Drug-Eluting Stent In-Stent Restenosis

Table 5

Multivariate analysis of factors affecting the occurrence of DES-ISR.

Index		SE	Wald’s	OR	95% CI	value
Abnormal BMI	2.281	1.282	3.166	9.786	0.793~120.750	0.076
Smoking	2.153	1.328	2.628	8.611	0.638~116.266	0.106
Hypertension	3.321	1.501	4.895	27.688	1.461~524.770	0.027
Diabetes	0.248	1.196	0.043	1.281	0.123~13.359	0.836
Family history of coronary heart disease	2.487	1.273	3.817	12.025	0.992~145.777	0.051
Number of arterial lesions	3.427	1.458	5.525	30.784	1.767~536.293	0.019
Stenosis target lesion degree	3.359	1.298	6.697	28.760	2.259~366.164	0.010
Target lesion diameter	-3.143	1.355	5.380	0.043	0.003~0.614	0.021
Target lesion length	0.650	0.211	9.490	1.916	1.267~2.897	0.002
Stent length	2.798	1.434	3.807	16.412	0.987~272.773	0.052
Stent diameter	-10.159	3.452	8.661	0.000	0.000~0.034	0.003
Number of stents	0.099	1.112	0.008	1.104	0.125~9.762	0.929
Constant	2.281	1.282	3.166	9.786	0.793~120.750	0.076

Assignment: abnormal BMI (yes was 1, no was 0); smoking (yes was 1, no was 0); hypertension (yes was 1, no was 0); diabetes (yes was 1, no was 0); family history of coronary heart disease (yes was 1, no was 0); number of coronary artery lesions (multiple vessels was 1, single vessel was 0); stenosis target lesion degree (≥85.05% was 1, <85.05% was 0); target lesion diameter (≥3.15 mm was 1, <3.15 mm was 0); stent diameter (≥3.15 mm was 1, <3.15 mm was 0); target lesion length (≥36.8 mm was 1, <36.88 mm was 0); stent length (≥22.07 mm was 1, <22.07 mm was 0); number of stents (≥2 was 1, <2 was 0).